Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
β Scribed by Wang, Chia-Chi; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Hsieh, Tsai-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Hsu, Ching-Sheng; Lin, Hans Hsienhong; Kao, Jia-Horng
- Book ID
- 118704566
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 173 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Current guidelines for management of chronic hepatitis B recommend treatment for patients presenting with elevated hepatitis B virus (HBV) DNA and alanine aminotransferase (ALT) >2 x upper limit of normal (ULN) or histological evidence of liver disease. Retrospective analyses have demonstrated that
## Abstract Recent studies have suggested that quantifying the serum HBsAg levels can predict the response to pegylated interferon. We aimed to determine the change in serum HBsAg levels during entecavir (ETV) treatment and the correlation with treatment response in chronic HBeAgβpositive and HBeAg